{"identifier":"/us/usc/t21/s399h","title_num":"21","num":"§ 399h.","heading":"Grants for studying continuous drug manufacturing","status":null,"guid":"id374e1923-4155-11e7-a62f-f6f64c68eb16","source_credit":"(Pub. L. 114–255, div. A, title III, § 3016, Dec. 13, 2016, 130 Stat. 1095.)","seq_in_title":362,"parent_identifier":"/us/usc/t21/ch9/schX","ancestors":[{"identifier":"/us/usc/t21","level":"title","num":"Title 21—","heading":"FOOD AND DRUGS","status":null,"is_section":false},{"identifier":"/us/usc/t21/ch9","level":"chapter","num":"CHAPTER 9—","heading":"FEDERAL FOOD, DRUG, AND COSMETIC ACT","status":null,"is_section":false},{"identifier":"/us/usc/t21/ch9/schX","level":"subchapter","num":"SUBCHAPTER X—","heading":"MISCELLANEOUS","status":null,"is_section":false}],"xml":"<section xmlns=\"http://xml.house.gov/schemas/uslm/1.0\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" style=\"-uslm-lc:I80\" id=\"ide50780f5-ec7d-11e6-944b-93361b188886\" identifier=\"/us/usc/t21/s399h\"><num value=\"399h\">§ 399h.</num><heading> Grants for studying continuous drug manufacturing</heading><subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"ide50780f6-ec7d-11e6-944b-93361b188886\" identifier=\"/us/usc/t21/s399h/a\"><num value=\"a\" class=\"bold\">(a)</num><heading class=\"bold\"> In general</heading><content><p style=\"-uslm-lc:I11\" class=\"indent0\">The Secretary of Health and Human Services may award grants to institutions of higher education and nonprofit organizations for the purpose of studying and recommending improvements to the process of continuous manufacturing of drugs and biological products and similar innovative monitoring and control techniques.</p>\n</content>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"ide50780f7-ec7d-11e6-944b-93361b188886\" identifier=\"/us/usc/t21/s399h/b\"><num value=\"b\" class=\"bold\">(b)</num><heading class=\"bold\"> Definitions</heading><chapeau>In this section—</chapeau><paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ide50780f8-ec7d-11e6-944b-93361b188886\" identifier=\"/us/usc/t21/s399h/b/1\"><num value=\"1\">(1)</num><content> the term “drug” has the meaning given such term in <ref href=\"/us/usc/t21/s321\">section 321 of this title</ref>;</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ide50780f9-ec7d-11e6-944b-93361b188886\" identifier=\"/us/usc/t21/s399h/b/2\"><num value=\"2\">(2)</num><content> the term “biological product” has the meaning given such term in <ref href=\"/us/usc/t42/s262/i\">section 262(i) of title 42</ref>; and</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ide50780fa-ec7d-11e6-944b-93361b188886\" identifier=\"/us/usc/t21/s399h/b/3\"><num value=\"3\">(3)</num><content> the term “institution of higher education” has the meaning given such term in <ref href=\"/us/usc/t20/s1001/a\">section 1001(a) of title 20</ref>.</content>\n</paragraph>\n</subsection>\n<sourceCredit id=\"ide50780fb-ec7d-11e6-944b-93361b188886\">(<ref href=\"/us/pl/114/255/dA/tIII\">Pub. L. 114–255, div. A, title III</ref>, § 3016, <date date=\"2016-12-13\">Dec. 13, 2016</date>, <ref href=\"/us/stat/130/1095\">130 Stat. 1095</ref>.)</sourceCredit>\n<notes type=\"uscNote\" id=\"ide50780fc-ec7d-11e6-944b-93361b188886\">\n<note style=\"-uslm-lc:I76\" topic=\"codification\" id=\"ide50780fd-ec7d-11e6-944b-93361b188886\"><heading class=\"centered smallCaps\">Codification</heading>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">Section was enacted as part of the 21st Century Cures Act, and not as part of the Federal Food, Drug, and Cosmetic Act which comprises this chapter.</p>\n</note>\n</notes>\n</section>","provision":null,"duplicates":[],"release":{"label":"115-35","currency_date":"2017-05-17","congress":115,"law_num":35,"excluded_laws":[],"update_num":null,"seq":99,"is_partial":false,"caveat":null,"titles_affected":["01","02","05","05a","06","07","08","10","12","15","16","19","20","21","22","23","26","28","30","31","33","36","38","40","41","42","43","48","49","50","51","54"],"ingested_titles":[]},"served_from":{"label":"115-35","currency_date":"2017-05-17","congress":115,"law_num":35,"excluded_laws":[],"update_num":null,"seq":99,"is_partial":false,"caveat":null,"titles_affected":["01","02","05","05a","06","07","08","10","12","15","16","19","20","21","22","23","26","28","30","31","33","36","38","40","41","42","43","48","49","50","51","54"],"ingested_titles":[]},"content_first_seen":{"label":"114-321","currency_date":"2016-12-16","congress":114,"law_num":321,"excluded_laws":[],"update_num":null,"seq":88,"is_partial":false,"caveat":null,"titles_affected":["05","15","21","26","28","29","38","42","48"],"ingested_titles":[]},"is_exact":true,"note":null}